INSPIREMD INC (NSPR) Fundamental Analysis & Valuation

NASDAQ:NSPR • US45779A8466

Current stock price

1.61 USD
+0.02 (+1.26%)
Last:

This NSPR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NSPR Profitability Analysis

1.1 Basic Checks

  • NSPR had negative earnings in the past year.
  • In the past year NSPR has reported a negative cash flow from operations.
  • In the past 5 years NSPR always reported negative net income.
  • In the past 5 years NSPR always reported negative operating cash flow.
NSPR Yearly Net Income VS EBIT VS OCF VS FCFNSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -58.87%, NSPR is doing worse than 70.74% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -72.05%, NSPR is in line with its industry, outperforming 43.62% of the companies in the same industry.
Industry RankSector Rank
ROA -58.87%
ROE -72.05%
ROIC N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
NSPR Yearly ROA, ROE, ROICNSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • NSPR has a Gross Margin of 24.91%. This is in the lower half of the industry: NSPR underperforms 78.19% of its industry peers.
  • NSPR's Gross Margin has been stable in the last couple of years.
  • NSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
NSPR Yearly Profit, Operating, Gross MarginsNSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NSPR Health Analysis

2.1 Basic Checks

  • NSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NSPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NSPR Yearly Shares OutstandingNSPR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NSPR Yearly Total Debt VS Total AssetsNSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -3.33, we must say that NSPR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -3.33, NSPR is doing worse than 65.43% of the companies in the same industry.
  • NSPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.33
ROIC/WACCN/A
WACC10.6%
NSPR Yearly LT Debt VS Equity VS FCFNSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 6.51 indicates that NSPR has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 6.51, NSPR belongs to the top of the industry, outperforming 82.45% of the companies in the same industry.
  • NSPR has a Quick Ratio of 6.17. This indicates that NSPR is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of NSPR (6.17) is better than 84.04% of its industry peers.
Industry RankSector Rank
Current Ratio 6.51
Quick Ratio 6.17
NSPR Yearly Current Assets VS Current LiabilitesNSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NSPR Growth Analysis

3.1 Past

  • NSPR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.28%.
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%61.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.34% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 87.18% on average over the next years. This is a very strong growth
EPS Next Y-2%
EPS Next 2Y8.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year72.3%
Revenue Next 2Y87.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

NSPR Yearly Revenue VS EstimatesNSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
NSPR Yearly EPS VS EstimatesNSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 -500K -1M -1.5M

More info and screens

Find the best growth stocksShow best growing peers

0

4. NSPR Valuation Analysis

4.1 Price/Earnings Ratio

  • NSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NSPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NSPR Price Earnings VS Forward Price EarningsNSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSPR Per share dataNSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.34%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NSPR Dividend Analysis

5.1 Amount

  • NSPR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NSPR Fundamentals: All Metrics, Ratios and Statistics

INSPIREMD INC

NASDAQ:NSPR (3/31/2026, 3:19:41 PM)

1.61

+0.02 (+1.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-18
Earnings (Next)05-07
Inst Owners47.29%
Inst Owner Change2.18%
Ins Owners19.31%
Ins Owner Change18.03%
Market Cap68.22M
Revenue(TTM)N/A
Net Income(TTM)-46.20M
Analysts82.22
Price Target5.1 (216.77%)
Short Float %0.07%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.25%
Min EPS beat(2)1.96%
Max EPS beat(2)14.53%
EPS beat(4)3
Avg EPS beat(4)3.28%
Min EPS beat(4)-7.84%
Max EPS beat(4)14.53%
EPS beat(8)5
Avg EPS beat(8)0.43%
EPS beat(12)9
Avg EPS beat(12)6.98%
EPS beat(16)13
Avg EPS beat(16)11.88%
Revenue beat(2)2
Avg Revenue beat(2)27.63%
Min Revenue beat(2)14.71%
Max Revenue beat(2)40.56%
Revenue beat(4)4
Avg Revenue beat(4)15.96%
Min Revenue beat(4)3.38%
Max Revenue beat(4)40.56%
Revenue beat(8)7
Avg Revenue beat(8)9.62%
Revenue beat(12)11
Avg Revenue beat(12)8.9%
Revenue beat(16)14
Avg Revenue beat(16)7.41%
PT rev (1m)0%
PT rev (3m)25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.34%
EPS NY rev (1m)1.38%
EPS NY rev (3m)1.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.77
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.81
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS0.18
BVpS1.51
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -58.87%
ROE -72.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.91%
FCFM N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 390.57%
Cap/Sales 20.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.51
Quick Ratio 6.17
Altman-Z -3.33
F-Score4
WACC10.6%
ROIC/WACCN/A
Cap/Depr(3y)304.1%
Cap/Depr(5y)236.96%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y-2%
EPS Next 2Y8.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%61.57%
Revenue Next Year72.3%
Revenue Next 2Y87.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-45.05%
EBIT Next 3Y-17.17%
EBIT Next 5YN/A
FCF growth 1Y-119.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.87%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIREMD INC / NSPR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INSPIREMD INC (NSPR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NSPR.


What is the valuation status for NSPR stock?

ChartMill assigns a valuation rating of 0 / 10 to INSPIREMD INC (NSPR). This can be considered as Overvalued.


Can you provide the profitability details for INSPIREMD INC?

INSPIREMD INC (NSPR) has a profitability rating of 1 / 10.


What is the expected EPS growth for INSPIREMD INC (NSPR) stock?

The Earnings per Share (EPS) of INSPIREMD INC (NSPR) is expected to decline by -2% in the next year.